How the Method of Bladder Emptying After Epidural Placement in Labor Affects Postpartum Voiding
NCT ID: NCT07125326
Last Updated: 2025-11-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
564 participants
INTERVENTIONAL
2025-11-30
2027-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Determination of Risk Factors of Postpartum Urinary Retention
NCT03876756
Optimizing the Management of Postpartum Urinary Retention
NCT04187365
RCT About Two Different Regimens of Clean Intermittent Catheterization in Women With Overt Postpartum Urinary Retention
NCT05188963
Treatment of Postpartum Urinary Retention
NCT04104165
Evaluation of Post-voiding Residual Urine: a Before-after, Post-partum Study
NCT02597413
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intermittent catheterization
Intermittent catheterization
intermittent bladder catheterization every four hours, or shorter intervals if volume exceeds 500mL per expert recommendation
Continuous catheterization
Continuous catheterization
One catheter is placed in the bladder until pushing
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intermittent catheterization
intermittent bladder catheterization every four hours, or shorter intervals if volume exceeds 500mL per expert recommendation
Continuous catheterization
One catheter is placed in the bladder until pushing
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 18 years and older
* Live fetus
* Receive epidural anesthesia
Exclusion Criteria
* those with stillbirth
* those with baseline overactive bladder symptoms, neurogenic bladder diagnoses, or otherwise using bladder catheterization during pregnancy
Patients will be excluded from UTI analyses if:
* they received antibiotics intrapartum
* had bacteriuria diagnosed by a clean catch specimen showing \>100,000 CFU/mL of a single bacterial species, regardless of symptoms
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Pittsburgh
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Elena Lands
Graduate Medical Fellow
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anna Binstock, MD
Role: STUDY_CHAIR
UPMC Magee-Womens Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UPMC Magee-Womens Hospital
Pittsburgh, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY24030142
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.